MBBS, BMedSc, FACD
PA/secretary phone number: 020 7794 0500 ext 33508/38134
PA/secretary email address: firstname.lastname@example.org
Fax: 020 7317 7645
Private practice phone number: 020 7183 4565
Dr Amanda Saracino completed her medical degree in Australia, finishing top of her graduating year and receiving the Sophie Davis Memorial Prize. She subsequently undertook her specialist dermatology training in tertiary teaching hospitals in Melbourne and London and was awarded both the Ken Paver and President’s medals for academic excellence in examinations during her training. Dr Saracino was subsequently the recipient of the Florance Bequest Fellowship, enabling her to complete a clinical and research fellowship in connective tissue diseases (eg lupus, morphoea, systemic sclerosis (“scleroderma”), dermatomyositis and raynaud’s) and complex medical dermatology.
Dr Saracino continues to be actively involved in academic research in the field of connective tissue diseases, with research grants and awards enabling her to continue this work. She also regularly teaches training doctors and dermatologists in the areas of complex medical dermatology and connective tissue diseases (CTD).
Dr Saracino undertakes general and medical dermatology clinics, weekly dermatology CTD clinics with the CTD service, and regular joint dermatology/rheumatology CTD clinics with the rheumatology scleroderma unit.
Dr Saracino is passionate about every aspect of her work and is devoted to going above and beyond to provide thorough and compassionate care for all her patients.
- Saracino AM, Denton CP, Orteu CH 2016, ‘The pathogenesis of morphoea; from genetics to future treatment targets’, British Journal of Dermatology, In press August 2016
- Saracino AM, Orteu CO 2016, ‘Severe recalcitrant cutaneous manifestations in systemic lupus erythematosus successfully treatment with fumaric acid esters’, British Journal of Dermatology, In press April 2016
- Saracino A, Gordon K, Ffolkes L & Mortimer P 2012, 'Intralymphatic granulomas in lymphoedema secondary to anogenital granulomatosis', Australasian Journal of Dermatology, vol 54, pp 50-61
- Saracino A, Kelly R, Lieu D, Chong A 2011, ‘Pyoderma gangrenosum requiring inpatient management: A report of 26 cases with follow-up’, Australasian Journal of Dermatology, vol 52. pp 218-21
- Pinder V, Eriyagama S, Saracino A, Wee J 2011, ‘Terra firma-forme dermatosis: another cause of reticulate hyperpigmentation’, Clinical & Experimental Dermatology
- Saracino A, Weiland T, Dent A, Jolly B 2010, ‘Verbal dyspnea score predicts ED departure status’, Emergency Medicine Australasia, vol 22. pp 22-29
- Saracino A, Weiland T, Dent A, Jolly B 2008, ‘Validation of a verbal dyspnoea rating scale in the emergency department’, Emergency Medicine Australasia, vol. 20, no. 6, pp. 475-481
- Saracino A, Weiland T, Dent A, Jolly B 2008, ‘Validation of a verbal rating scale for breathlessness amongst patients referred for cardiac stress tests’, Heart, Lung Circulation, vol. 17, issue 4, pp. 305-312
- Saracino A, 2007, ‘Review of dyspnea quantification in the emergency department: Is a rating scale for breathlessness suitable for use as an admission prediction tool?’ Emergency Medicine Australasia, vol. 19, no. 5, pp. 394-404.
- Saracino A, Weiland T, Dent A, Jolly B 2006, ‘Can patient subjective ratings of breathlessness predict emergency department departure status?’ Thorax, vol 61 (suppl 2), pp. 41.